串聯臨床、數據與研究
合作洽詢聯絡我們
← 返回研究成果

RESEARCH PUBLICATION / 2025

通信 · Correspondence / Letter

Unexplored limitations in a randomized trial that examines efficacy and safety of upadacitinib or elsubrutinib alone or in combination for patients with systemic lupus erythematosus: comment on the article by Merrill et al.

Arthritis & Rheumatology

論文與作者

Arthritis Rheumatol. 2025;77(8):1108.

Qianyu Guo; Junkang Zhao; Li-Yun Zhang; James Cheng-Chung Wei

摘要與原文

目前公開索引未提供摘要,請參閱期刊原文。

前往期刊頁面